Portfolio Grader currently ranks CR Bard Inc (NYSE:BCR) a Strong Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. BCR has maintained this ranking for 3 months.

As one of the 785 companies in the GICS Health Care sector the company is a member of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of BCR is $24.3 billion which places it in the top 10% of its industry group Currently, the stock's Portfolio Grader ranking places it 20 among the 164 companies in this industry group, putting in the top quartile.

Portfolio Grader currently ranks the Health Care sector number 10 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 40 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

BCR has achieved well above-average scores in 1, and above-average scores in 0 of the 8 fundamental metrics used by Portfolio Grader in the ranking of company stocks.

The company's operational scores are below the industry norms for sales growth, operating margin, and earnings growth. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. BCR's ranking for return on equity is significantly better than its industry group average but its grade for cash flow is below-average. Based on these fundamental scores, CR Bard places in the top half of the industry group.

Portfolio Grader uses the Navellier Proprietary Quantitative Score to view BCR's shares from the aspect of risk/reward. This proprietary scoring system takes into account the relative value of BCR's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Based on this risk/reward calculation, the company currently scores well above-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.